Global Photodynamic Therapy Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Drugs (Porphyrin Derivative (PD), Hematoporphyrin Derivative (HpD), Benzoporphyrin Derivative (BPD), Texaphyrins , Others, Aminolevulinic acid (ALA), Chlorines and Others), Devices -(Disposable Fiber Optic Light Delivery Devices (DFOLDD), and Diode Laser).

By Application;

Cancer -(Basal Cell Carcinoma, Non-small Cell Lung Cancer, Head & Neck Cancer and Others), Actinic Keratosis (AK), Psoriasis, Acne, and Others.

By End User;

Hospitals, Cosmetics & Dermatology Clinics, and Cancer Treatment Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn165704816 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Photodynamic Therapy Market (USD Million), 2021 - 2031

In the year 2024, the Global Photodynamic Therapy Market was valued at USD 5,460.99 million. The size of this market is expected to increase to USD 10,507.22 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.8%.

The global photodynamic therapy (PDT) market is experiencing robust growth, driven by the increasing adoption of this innovative treatment modality across various medical specialties. Photodynamic therapy involves the use of photosensitizing agents and specific wavelengths of light to selectively target and destroy diseased cells while minimizing damage to surrounding healthy tissue. This minimally invasive approach offers significant advantages over traditional treatment modalities, including reduced side effects, improved cosmetic outcomes, and shorter recovery times.

In recent years, photodynamic therapy has gained traction in the treatment of various medical conditions, including cancer, dermatological disorders, ophthalmic diseases, and microbial infections. In oncology, PDT is being increasingly utilized as a primary or adjuvant treatment for various types of cancer, including skin cancer, lung cancer, and certain types of head and neck cancers. The ability of PDT to selectively target cancerous cells while sparing healthy tissue makes it a promising option for patients seeking effective and well-tolerated cancer therapies.

In dermatology, photodynamic therapy is widely used for the treatment of acne, actinic keratosis, and other skin conditions. Its ability to target abnormal skin cells with precision makes it a highly effective option for patients seeking non-invasive and cosmetically appealing treatments. Additionally, PDT is gaining popularity in ophthalmology for the treatment of age-related macular degeneration and other retinal disorders, where it offers a targeted approach to preserving vision and slowing disease progression.

The global photodynamic therapy market is also fueled by ongoing advancements in technology, including the development of next-generation photosensitizing agents, improved light delivery systems, and enhanced treatment protocols. These innovations are expanding the scope of photodynamic therapy applications and improving treatment outcomes across various medical specialties.

The market also faces challenges, including regulatory hurdles, limited reimbursement policies, and the need for greater awareness among healthcare providers and patients. Overcoming these challenges will be crucial for unlocking the full potential of photodynamic therapy and driving market growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Photodynamic Therapy Market Trends
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Minimally invasive
        2. Selective targeting
        3. Reduced side effects
        4. Improved cosmetic outcomes
      2. Restraints
        1. Regulatory hurdles
        2. Limited reimbursement
        3. Awareness gaps
        4. Complexity of treatment
      3. Opportunities
        1. Expanding applications
        2. Aging population
        3. Technological advancements
        4. Emerging markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Photodynamic Therapy Market, By Product, 2021 - 2031 (USD Million)
      1. Drugs
        1. Porphyrin Derivative (PD)
        2. Hematoporphyrin Derivative (HpD)
        3. Benzoporphyrin Derivative (BPD)
        4. Texaphyrins
        5. Others
        6. Aminolevulinic acid (ALA)
        7. Chlorines
        8. Others
      2. Devices
        1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)
        2. Diode Laser
    2. Global Photodynamic Therapy Market, By Application, 2021 - 2031 (USD Million)
      1. Cancer
        1. Basal Cell Carcinoma
        2. Non-small Cell Lung Cancer
        3. Head & Neck Cancer
        4. Others
      2. Actinic Keratosis (AK)
      3. Psoriasis
      4. Acne
      5. Others
    3. Global Photodynamic Therapy Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Cosmetics & Dermatology Clinics
      3. Cancer Treatment Centers
    4. Global Photodynamic Therapy Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Biofrontera AG
      2. Theralase Technologies Inc.
      3. Quest PharmaTech Inc.
      4. Modulight, Inc.
      5. Galderma Laboratories L.P. (Nestlé)
      6. Sun Pharmaceutical Industries Ltd.
      7. SUS Advancing Technology Co., Ltd
  7. Analyst Views
  8. Future Outlook of the Market